It's all about the bottom line period. - Recensione dipendente - Dipendente anonimo presso Sanofi

4,0
24 ott 2014
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Genzyme is still a decent company. The compensation is still good although there have been changes in the past 2 years or so and it is becoming more difficult to make full bonus. Work-life balance is still good. The acquisition by Sanofi has been challenging and their influence is being felt more and more.

Svantaggi

Senior Management is overly focused on metrics, many of which are not meaningful, The introduction of the daily time card has contributed to this issue. The acquisition of Genzyme by Sanofi over 3 years ago has not been as positive as Sanofi would have employees at Genzyme believe. Many of the legacy Genzyme employees have left the company to pursue other start up opportunities or to retire. A tremendous amount of talent, knowledge and expertise went with those employees who left.

Esplora altre recensioni su Sanofi

5,0
8 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great company to work for

Svantaggi

promotions are very hard to come by

5,0
31 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The company has an excellent, very collegial atmosphere. Employees are supported well and there is excellent support for most processes from numerous line functions.

Svantaggi

Some processes as well as the governance structure can be a bit confusing. More so than other large pharma companies. But even with this. There are almost always enough people who know how to get things done.

Vedi recensioni per: Utile|Valutazione|Data|Tutto